The 6 minute walk test (6 MWT) has been shown to provide a clinically useful index of functional capacity in chronic heart failure. We hypothesized that similar results would be found in patients who had a recent (ie, within a week) myocardial infarction (MI). Twenty-five patients (23 males, aged 43 to 72 years) who had undertaken an exercise stress test without complications underwent 3 consecutive 6 MWTs (1 hour apart). Heart rate, systolic and diastolic blood pressure, the level of perceived exertion (Borg scale), and the walking distance were determined. In addition, chest pain was assessed by a 0 to 10 numerical rating scale (NRS) and the ECG was continuously monitored. All subjects were able to successfully complete the exercise tests without major cardiovascular complications: mild chest pain (NRS 1 to 3) was found in 3 patients. A Bland-Altman analysis revealed that the mean bias ± 95% confidence interval of the differences on distance walked between test 2 -test 1 were substantially higher than test 3 -test 2 differences (18 ± 66 m and 6 ± 41 m, respectively). The intraclass correlation coefficients were consistently high for all physiological and sensorial responses at the end of the 6 MWTs (range, 0.75 to 0.95). The 6 MWT is a safe and reproducible measurement of functional capacity in stable patients after a noncomplicated MI, even when performed within a week of the event. Therefore, this test might be useful for the evaluation of exercise tolerance in phases I and II of inpatient cardiovascular rehabilitation programs or to assess functional responses to selected interventions. (Int Heart J 2006; 47: 533-540) 
functional capacity in a number of conditions, such as chronic obstructive pulmonary disease (COPD), 4) pulmonary hypertension, 5) and chronic renal failure. 6) In clinical cardiology, unfortunately, the test has been largely restricted to the evaluation of patients with chronic heart failure (CHF). [7] [8] [9] [10] Although the American Thoracic Society guideline for the 6 MWT states that a "recent" (within a month) MI is an absolute contraindication for the test, 11) few data are available to support this contention. In fact, to the best of our knowledge, no previous study has looked at the safety, reliability, and repeatability of the 6 MWT in patients recovering from an acute MI.
Therefore, the objective of the present study was to determine whether the 6 MWT would provide a robust index of functional capacity in a group of patients who had a recent MI (within a week).
METHODS
Patients: Twenty-five inpatients (23 males), aged 43 to 72 years, with a diagnosis of myocardial infarction (MI) in the preceding 4 to 7 days (median of 6 days) participated in this prospective, cross-sectional study. MI was defined by the presence of a biochemical marker of myocardial necrosis (cardiac troponin T and/ or MB fraction of creatine kinase) in a patient with typical symptoms who also presented with pathological Q waves and/or elevation or depression of the ST segment (Table I) . 1) Treatment for acute MI included percutaneous angioplasty (1), thrombolysis (2) , and clinical therapy only (3). The patients were under standard medical therapy (including β-blockers) and they were considered to be clin- 12) in a 33 meter long internal corridor. Three tests were performed on the same day, one hour apart. Participants were instructed to "walk from one end of the corridor to the other at their own pace, in order to cover as much ground as possible." Every 30 seconds, the investigator encouraged the participants with the standardized statements "You're doing well" or "Keep up the good work". Participants were allowed to stop and rest during the test, but were instructed to resume walking as soon as they were able to do so. During the test, cardiac rhythm was continuously followed using a Holter system (Dynamis 3000, Sao Paulo, Brazil) and the heart rate (HR, bpm) was recorded on a HR counter (Polar Accurex Plus, Kempele, Finland). At the end of the 6 MWTs, the respiratory rate (RR, rpm) was checked and the systolic and diastolic blood pressures were measured (SBP and DBP in mmHg, respectively). In addition, participants were shown a Borg perceived effort scale and asked to "indicate your current degree of effort perception" on a scale of "6 = nothing at all" to "20 = maximal". 13) They were also asked if they had experienced any chest pain by using a 0 to 10 numerical rating scale (NRS): 0 = "no pain at all"; 1-3 = "mild pain"; 4-6 = "moderate pain"; 7-9 = "severe pain"; 10 = "unbearable pain".
14) The distance walked was compared with gender-specific predicted values. 15) Statistical Analysis: Data are expressed as the mean and standard deviation (SD), with the exception of Borg scores (median and ranges). The limits of agreement between the variables at the end of the 6 MWTs were investigated by plotting the individual differences against their means (Bland-Altman analysis). Heteroscedasticity was examined by plotting the absolute differences against the individual means and calculating the Spearman's correlation coefficient. 16) If the correlation was close to zero, the mean bias and the 95% limits of agreement were calculated as mean ± 1.96 SD of the between-estimate differences. In addition, the intraclass correlation coefficients (ICC) were calculated: an ICC ≥ above 0.75 was indicative of a high intratest repeatability.
RESULTS
All patients were able to successfully complete the proposed tests. There were no clinically significant changes on the ST-segment or complex ventricular arrhythmias. Isolated ectopic ventricular beats (EVBs) were found in 3 patients in the 1 st and 2 nd tests, but only 1 patient showed EVBs in the 3 rd test. Three other patients presented with mild chest pain (NRS = 1 to 3), which was reproducible in 2. 7 -17) Values are expressed as the mean ± SD (with the exception of the Borg score: median and range) Figure. Bland-Altman plot of the between-test differences in the distance walked in 6 minutes (6 MWT) as a function of their means. Note that the mean bias (95% confidence interval) was narrower for the differences between the 3 rd and 2 nd tests (8 ± 41 m) than the 2 nd to 1 st test differences (18 ± 66 m).
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The mean distance walked in all tests was close to the predicted value for a normal, elderly population, however, the values were slightly lower on the 1st test (Table II) . 15) In fact, the Bland-Altman analysis showed that the distance walked increased on the 2 nd as compared to the 1 st trial, but remained stable on the 3 rd test. Therefore, the mean bias ± 95% confidence interval of the 3 rd -2 nd and 2 nd -1 st test differences were 6 ± 41 and 18 ± 66 m, respectively (Figure) . In addition, high ICCs were observed (Table III) .
As shown in Table II , the physiological and perceptual responses to the 6 MWTs were also highly reproducible. After certification of data homocedasticity (see Data Analysis), Bland-Altman analysis revealed that the between-test limits of agreement (mean bias ± 95% confidence interval) for the main variables were larger for the 2 nd -1 st test than the 3 rd -2 nd test differences: HR = 1 ± 10 versus 1 ± 8 bpm; SBP = -3 ± 19 versus 3 ± 13 mmHg; DBP = 1 ± 12 versus -3 ± 10 mmHg; RR = 1 ± 5 versus 1 ± 3 rpm; and double product = -63 ± 2708 versus 323 ± 1981 bpm.mmHg. Similar to the walking distance, the lower limit of the 95% confidence intervals was ≥ 0.75 in all cases (Table III) .
DISCUSSION
The findings of this study have demonstrated that a simple and widely-used measurement of functional capacity (6 MWT) is a safe and reproducible procedure in patients who had a noncomplicated MI within a week of the tests. The tests, however, should be performed on duplicate to enhance their accuracy. This is the first study to look at the clinical reliability of the 6 MWT in this patient population. These data are of particular relevance since the evaluation of patient functional capacity may provide important information to assess a prognosis and response to therapy, as well as to guide exercise training prescription. [18] [19] [20] [21] The 6 MWT is a field exercise test which has gained popularity in the past 2 decades. Its metabolic, ventilatory, and cardiovascular demands are consistent with a submaximal test, at least in patients with COPD and CHF. 4, 11, 12, 21) The American Heart Association recommends that a maximum effort test should be avoided within 2 weeks after an acute myocardial infarction. 22) Our data suggest that this was the case in the present study: HR during the 6 MWT, for instance, averaged 59 ± 7% of the maximal predicted by age. In this context, the lack of studies involving the 6 MWT in MI patients is somewhat surprising: measures of submaximal exercise capacity have been formally recommended before hospital discharge after acute MI. 18) In the present study, all patients were able to successfully complete the tests and the mean distance walked was close to the value predicted from healthy subjects (Table II) . 15) These data suggest that our patients exercised at relatively high metabolic demands -even after a recent MI. Future studies are needed to evaluate whether the distance walked or the ability to complete the 6 MWT provides a useful prognostic index in these patients.
Timed-walk tests were initially used in patients with chronic lung diseases who were unable to perform a formal exercise test due to extreme breathlessness. 4) In CHF, such tests have been widely applied to assess the responses to pharmacological interventions and as a useful prognostic indicator. [18] [19] [20] [21] These tests possess a number of advantages such as their simplicity, safety, and negligible cost. Although the 6 MWT correlated moderately well with peak VO 2 , it seems to be more adequate at providing an index of the ability of a patient to carry on their daily life activities.
The reproducibility of timed-walk tests is thought to be generally good, with intrasubject coefficients of variation averaging < 10%. 7, 12) In fact, we did find a high ICC for the distance walked (0.879), which is consistent with the values described by others in CHF (0.80-0.91). [7] [8] [9] [10] However, we found a clear learning effect from the 1 st to the 2 nd test with a much narrower variation between the 2 nd and 3 rd tests (Figure) . The differences were of practical relevance since the 95% confidence interval of the 2 nd -1 st test differences was higher than 50 m -a cutoff proposed by the American Thoracic Society as clinically relevant. 11) Our data, therefore, indicate that 2 consecutive 6 MWTs should be performed in this patient population and the distance walked on the 2 nd trial better reflects the true measurement. In addition to the distance walked, we also showed that the repeatability of some easily obtained measures of physiological and sensorial stresses was also excellent. Study limitations: This study involved a relatively small number of patients (n = 25), therefore, it cannot be ruled out that a lower degree of repeatability may be found if a larger and more heterogeneous population had been evaluated. This is especially true if we consider that all patients were clinically stable after experiencing a noncomplicated MI; in addition, the patients had previously undergone an event-free incremental treadmill test. Consequently, the pretest probability of • a serious adverse event was quite low in this selected population. Future studies should determine whether our results are also applicable to a more severe population, especially those patients with a worse health status. In addition, although our data are encouraging, it remains to be determined whether the 6 MWT can be a substitute for the traditional, but more demanding, tests of functional capacity in assessing the prognosis and responses to therapy after MI. Conclusions: The 6 MWT, when performed in duplicate, provided a safe, reliable and reproducible measurement of functional capacity in patients with stable, noncomplicated myocardial infarction, even when performed within a week of the event. The clinical usefulness of the test in assessing the prognosis and long-term response to therapy in this patient population remains to be established. The 6 MWT might prove to be useful for the evaluation of exercise tolerance in phases I and II of inpatient cardiovascular rehabilitation programs or to assess functional responses to selected interventions early after the acute event.
